NCT02119130View on ClinicalTrials.gov

Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa

NACompletedINTERVENTIONAL
Enrollment

3,506

Participants

Timeline

Start Date

November 1, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

May 31, 2019

Conditions
Latent TuberculosisHIV
Interventions
DEVICE

QGIT

Seven pairs of clinics will be included in this study. One clinic in each pair will be selected by a computerized randomization program to be the standard of care arm (TST only) and the other will be in the QGIT arm.

Trial Locations (14)

Unknown

Bothabelo CHC, Klerksdorp

Grace Mokhomo, Klerksdorp

Jouberton, Klerksdorp

Marcus Zenzile, Klerksdorp

NM Pretorious Gateway, Klerksdorp

Orkney, Klerksdorp

Park Street, Klerksdorp

Stilfontein, Klerksdorp

Tshepong Wellness Clinic, Klerksdorp

Tsholofelo, Klerksdorp

Boiki Tihapi, Potchefstroom

Potchefstroom Gateway, Potchefstroom

Potchefstroom, Potchefstroom

Steve Tshwete, Potchefstroom

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Witwatersrand, South Africa

OTHER

lead

Johns Hopkins University

OTHER

NCT02119130 - Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa | Biotech Hunter | Biotech Hunter